• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Sciences

    Still reeling from rejection, BioMarin reports a glimpse of those 2Y valrox data

    ENDPTS

    Gene Therapy Stocks - A Buying Opportunity

    SEEKING ALPHA

    BioMarin submits NDA for controversial achondroplasia drug

    ENDPTS

    ‘Huge Step Back’ for Hemophilia Gene Therapy, Expert Says of FDA Delay

    HEMOPHILIANEWSTODAY

    A cure for hemophilia is closer than ever. For patients, it could be just out

    BIOPHARMADIVE

    Gene Therapies Will Be A Bigger Cost Issue In 2021, PwC Predicts

    PHARMAINTELLIGENCE

    Investigational Gene Therapy Results in Huge Drop in Bleeding Rates VIII Usage

    HEMOPHILIANNEWSTODAY

    Thousands of sickle cell and hemophilia patients are waiting for gene therapies

    STAT NEWS

    Palynziq (pegvaliase-pqpz) for the Treatment of Phenylketonuria

    DRUG DEVELOPMENT TECH

    Dengue kills 21 in Indian tourist hotspot, crisis looms

    REUTERS

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.